FMC · Fmc Corp - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · FMC

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$3.47B	$4.25B	$4.49B	$5.80B	$5.05B	$4.64B
Cost of Revenue	$2.18B	$2.60B	$2.66B	$2.60B	$2.87B	$2.59B
Gross Profit	$1.28B	$1.65B	$1.83B	$2.33B	$2.17B	$2.05B
R&D	$266.10M	$278.00M	$328.80M	$314.20M	$304.70M	$287.90M
SG&A	$684.90M	$644.60M	$734.30M	$775.20M	$714.10M	$729.70M
Total Operating Expenses	$5.10B	$3.74B	$3.93B	$4.66B	$3.74B	-
D&A	$173.60M	$176.30M	$184.30M	$169.40M	$170.90M	$162.70M
Operating Income	($1.63B)	$506.50M	$555.60M	$1.14B	$1.04B	$902.20M
Interest Expense	$239.60M	$235.80M	$237.20M	$151.80M	$131.10M	$151.30M
Income Tax	$314.20M	($150.90M)	($1.12B)	$145.20M	$91.60M	$150.90M
Net Income	($2.24B)	$341.10M	$1.32B	$736.50M	$736.50M	$551.50M
EPS - Basic	($17.88)	$2.73	$10.55	$5.83	$5.72	$4.24
EPS - Diluted	($17.88)	$2.72	$10.53	$5.81	$5.70	$4.22

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$584.50M	$357.30M	$302.40M	$572.00M	$516.80M	$568.90M
Accounts Receivable	$2.06B	$2.90B	$2.70B	$2.87B	$2.58B	$2.33B
Inventory	$1.22B	$1.20B	$1.72B	$1.65B	$1.41B	$1.10B
Accounts Payable	$771.00M	$768.50M	$602.40M	$1.25B	$1.14B	$946.70M
Current Assets	$4.96B	$4.96B	$5.13B	$5.44B	$4.94B	$4.38B
Total Assets	$9.69B	$11.65B	$11.93B	$11.17B	$10.58B	$10.19B
Current Liabilities	$3.76B	$3.02B	$3.38B	$3.80B	$3.52B	$2.83B
Long-term Debt	$2.77B	$3.03B	$3.02B	$2.73B	$2.73B	$2.93B
Total Liabilities	-	-	-	-	-	-
Stockholders' Equity	$2.07B	$4.49B	$4.41B	$3.38B	$3.03B	$2.96B
Retained Earnings	$4.17B	$6.64B	$6.59B	$5.56B	$4.99B	$4.51B

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	($6.20M)	$736.70M	($300.30M)	$660.00M	$898.60M	$736.80M
Investing Cash Flow	($99.70M)	$263.60M	($154.40M)	($266.40M)	($131.70M)	($200.40M)
Financing Cash Flow	$386.00M	($870.10M)	$331.50M	($250.30M)	($747.90M)	($250.30M)
CapEx	$96.30M	$67.90M	$133.90M	$142.30M	$100.10M	$67.20M
Free Cash Flow	($102.50M)	$668.80M	($434.20M)	$517.70M	$798.50M	$669.60M

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	37.0%	38.8%	40.8%	40.1%	43.0%	44.2%
Operating margin	-47.0%	11.9%	12.4%	19.7%	20.7%	19.4%
EBITDA margin	-42.0%	16.1%	16.5%	22.6%	24.1%	22.9%
Net margin	-64.6%	8.0%	29.5%	12.7%	14.6%	11.9%
Free cash flow margin	-3.0%	15.8%	-9.7%	8.9%	15.8%	14.4%
FCF / Net income	0.05	1.96	-0.33	0.70	1.08	1.21
R&D / Revenue	7.7%	6.5%	7.3%	5.4%	6.0%	6.2%
SG&A / Revenue	19.8%	15.2%	16.4%	13.4%	14.2%	15.7%
Effective tax rate	-	-79.3%	-553.6%	16.5%	11.1%	21.5%
Return on assets	-23.1%	2.9%	11.1%	6.6%	7.0%	5.4%
Return on equity	-108.1%	7.6%	30.0%	21.8%	24.3%	18.6%
Return on invested capital	-26.6%	6.7%	7.5%	15.6%	16.1%	12.0%
Liquidity
Current ratio	1.32	1.64	1.52	1.43	1.40	1.55
Quick ratio	1.00	1.24	1.01	1.00	1.00	1.16
Cash ratio	0.16	0.12	0.09	0.15	0.15	0.20
Leverage
Debt / Equity	1.34	0.67	0.69	0.81	0.90	0.99
Debt / Assets	0.29	0.26	0.25	0.24	0.26	0.29
Debt / EBITDA	-	4.43	4.09	2.08	2.25	2.75
Interest coverage	-6.8x	2.1x	2.3x	7.5x	8.0x	6.0x
Equity multiplier	4.68	2.60	2.70	3.31	3.49	3.44
Liabilities / Assets	-	-	-	-	-	-
Efficiency
Asset turnover	0.36	0.36	0.38	0.52	0.48	0.46
Inventory turnover	1.79	2.16	1.54	1.57	2.04	2.36
Days sales outstanding	217d	250d	220d	181d	187d	183d
Days inventory outstanding	204d	169d	237d	232d	179d	154d
Days payable outstanding	129d	108d	83d	176d	144d	133d
Cash conversion cycle	292d	310d	374d	237d	221d	204d
Valuation
P / E	-	17.9x	6.0x	21.5x	19.3x	27.2x
P / B	0.8x	1.4x	1.8x	4.7x	4.7x	5.1x
P / S	0.5x	1.4x	1.8x	2.7x	2.8x	3.2x
EV / EBITDA	-	12.8x	14.4x	13.7x	13.5x	16.3x
Growth
Revenue growth (YoY)	-18.3%	-5.4%	-22.7%	15.0%	8.7%	0.7%
Revenue CAGR (3y)	-15.8%	-5.6%	-1.1%	8.0%	2.2%	17.3%
Revenue CAGR (5y)	-5.7%	-1.6%	-1.0%	15.0%	9.0%	7.2%
Gross profit growth (YoY)	-22.2%	-9.9%	-21.3%	7.1%	5.8%	-1.5%
Operating income growth (YoY)	-	-8.8%	-51.4%	9.5%	15.8%	9.8%
Net income growth (YoY)	-	-74.2%	79.4%	0.0%	33.5%	15.5%
EPS growth (YoY)	-	-74.2%	81.2%	1.9%	35.1%	16.6%
EPS CAGR (3y)	-	-21.9%	35.6%	17.1%	15.6%	1.9%
EPS CAGR (5y)	-	-5.6%	23.3%	7.8%	29.6%	2.9%
FCF growth (YoY)	-	-	-	-35.2%	19.3%	45.0%
FCF CAGR (5y)	-	7.7%	-	17.7%	14.5%	-
Book value growth (YoY)	-53.8%	1.7%	30.6%	11.4%	2.4%	17.0%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Product / service

$3.47B total

Insecticides$1.57B · 45.4%

Herbicides$1.25B · 36.0%

Fungicides$362.80M · 10.5%

Plant Health$190.90M · 5.5%

Product And Service Other$94.10M · 2.7%

Geographic

$5.51B total

Latin America$1.35B · 24.5%

BR$1.12B · 20.3%

North America$1.10B · 20.0%

US$923.10M · 16.8%

EMEA$871.50M · 15.8%

Asia$142.30M · 2.6%

Stability scores

Piotroski F-score

FY 2025 · 9-point quality

3/9

Weak

✗Net income positive
✗Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
✓Long-term debt decreased
✗Current ratio improved
✓No share dilution
✗Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Chemicals & Allied Products

Company	Revenue (last FY)	Net margin	ROE
CC	$5.81B	-6.6%	-154.4%
OLN	$6.78B	-1.5%	-5.5%
NGVT	$1.17B	-14.3%	-562.6%
IOSP	$1.78B	6.6%	8.8%
HUN	$6.04B	-3.1%	-6.9%

Comparing FMC CORP against the 5 most active filers in the same SIC group.

Dividends

$1.32/share trailing 12 months · -43.1% YoY

Ex-date	Per share
Mar 31, 2026	$0.0800
Dec 31, 2025	$0.0800
Sep 30, 2025	$0.5800
Jun 30, 2025	$0.5800
Mar 31, 2025	$0.5800
Dec 31, 2024	$0.5800
Sep 30, 2024	$0.5800
Jun 28, 2024	$0.5800
Mar 27, 2024	$0.5800
Dec 28, 2023	$0.5800
Sep 28, 2023	$0.5800
Jun 29, 2023	$0.5800
Mar 30, 2023	$0.5800
Dec 29, 2022	$0.5800
Sep 29, 2022	$0.5300
Jun 29, 2022	$0.5300
Mar 30, 2022	$0.5300
Dec 30, 2021	$0.5300
Sep 29, 2021	$0.4800
Jun 29, 2021	$0.4800
Mar 30, 2021	$0.4800
Dec 30, 2020	$0.4800
Sep 29, 2020	$0.4400
Jun 29, 2020	$0.4400